SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AxoGen, Inc. (AXGN)
NEW YORK, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers AxoGen, Inc. (“AxoGen” or the “Company”) (NASDAQ: AXGN). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/axgn.
The investigation concerns whether AxoGen and certain of its officers and/or directors have violated federal securities laws.
On December 18, 2018, Seligman Investments reported that “[a] number of former [AxoGen] employees allege channel stuffing [at AxoGen], given that the company’s consignment model creates potential for abuse, as well as alleging questionable revenue recognition practices.” The article continued to state that “allegations additionally include misleading operating metrics, with one former rep implying that the company’s definition of ‘active accounts’ may overstate the actual number by a factor of ten.” Following this news, AxoGen stock dropped $6.17 per share, or roughly 22%, to close at $21.36 on December 18, 2018.
If you are aware of any facts relating to this investigation, or purchased AxoGen shares, you can assist this investigation by visiting the firm’s site: bgandg.com/axgn. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | firstname.lastname@example.org